Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 5/20 | 0.34 |
| ▸ | TCF4 | P15884 | 2/20 | 0.34 |
| ▸ | CDH1 | P12830 | 1/20 | 0.34 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | KMO | O15229 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475336 | 0.76 | TRPA1 (0.36) | CYP1A2CTNNB1 | |
| SCHEMBL16617337 | 0.76 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL20719525 | 0.76 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL5400766 | 0.76 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL16617402 | 0.76 | CYP1A2 (0.42) | CYP1A2HTR2AHTR2CHTR2BKMO | |
| SCHEMBL3482763 | 0.74 | CYP1A2 (0.45) | CYP1A2HTR2AHTR2CHTR2BKMO | |
| Water SCHEMBL2123597 | 0.74 | CYP1A2 (0.47) | CYP1A2CTNNB1TCF4CDH1TCF7L2 | |
| SCHEMBL16097020 | 0.73 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL16616808 | 0.73 | CYP1A2 (0.37) | CYP1A2 | |
| SCHEMBL2466268 | 0.73 | CHEK1 (0.40) | KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0991638-A1 | NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS | Du Pont Pharmaceuticals Company (US) | 2000-04-12 | — | — | EP | claimed |
| WO-1998057951-A1 | NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-12-23 | — | — | WO | claimed |